| Literature DB >> 35281982 |
Neda Kabiri1, Rahim Khodayari-Zarnaq1, Manouchehr Khoshbaten2, Ali Janati1.
Abstract
This qualitative systematic review was conducted to summarize the policies for prevention of common gastrointestinal cancers worldwide. This study was conducted using PubMed, Web of Science, SCOPUS, and ProQuest databases. Two independent reviewers assessed included studies for methodological quality and extracted data by using standardized tools from Joanna Briggs Institute (JBI). Primary study findings were read and reread to identify the strategies or policies used in the studies for prevention of gastrointestinal cancers. The extracted findings were categorized on the basis of their similarity in meaning. These categories were then subjected to a meta-synthesis. The final synthesized findings were graded according to the ConQual approach for establishing confidence in the output of qualitative research synthesis. From the nine included studies in this review, 39 findings were extracted and based on their relevance in meaning were aggregated into 12 categories. Four synthesized findings were developed from these categories. We used World Health Organization report on 2000 for synthesizing the findings. The four synthesized findings were "service provision", "resource generation", "financing", and "stewardship". In order to reach a comprehensive evidence informed policy package for the prevention of gastrointestinal cancers, there should be a great communication among the interventions conducted directly on patients, health system infrastructures, and resources. Copyright:Entities:
Keywords: Gastrointestinal cancer; policy; primary prevention; secondary prevention; strategy
Year: 2022 PMID: 35281982 PMCID: PMC8883678 DOI: 10.4103/ijpvm.IJPVM_419_20
Source DB: PubMed Journal: Int J Prev Med ISSN: 2008-7802
Figure 1Search results and study selection and inclusion process
Assessment of methodological quality of included studies
| Criteria/Studies | Bridges | Jilcott Pitts | Buchman | Clavarino | Dowson | Dowswell | Goel | Liles | Sarfaty |
|---|---|---|---|---|---|---|---|---|---|
| Congruity between the stated philosophical perspective and the research methodology | Y | Y | Y | Y | Y | Y | Y | Y | Y |
| Congruity between the research methodology and the research objectives | Y | Y | Y | Y | Y | Y | Y | Y | Y |
| Congruity between the research methodology and the methods used to collect the data | Y | Y | N | Y | Y | Y | Y | Y | Y |
| Congruity between the research methodology and the representation and analysis of data | Y | Y | Y | Y | Y | Y | Y | Y | Y |
| Congruity between the research methodology and the interpretation of results | Y | Y | Y | Y | Y | Y | Y | Y | Y |
| Statement locating the researcher culturally or theoretically | N | N | N | N | N | N | N | N | N |
| The influence of the researcher on the research, and vice-versa, is addressed | U | Y | U | U | Y | U | U | Y | U |
| Participants, and their voices, are represented adequately | Y | Y | Y | Y | Y | Y | Y | Y | Y |
| Research is ethical | Y | Y | Y | Y | Y | Y | Y | Y | U |
| Conclusions appear to flow from the analysis or interpretation of the data | Y | Y | Y | Y | Y | Y | Y | Y | Y |
| Total | 8 | 9 | 7 | 8 | 9 | 8 | 8 | 9 | 7 |
Y: Yes, N: No, U: Unclear
ConQual summery of findings
| Systematic review title: Policies for prevention of common gastrointestinal cancers | |||||
| Population: Patients of any age, gender and cultural background that has been prevented from a common gastrointestinal cancer, physicians and all health services providers, managers and policy makers. | |||||
| Phenomena of interest: Policies and strategies for prevention of common gastrointestinal cancers | |||||
| Context: Studies conducted in any country | |||||
|
| |||||
|
|
|
|
|
|
|
|
| |||||
| Service provision | Qualitative | Moderate * | Downgraded 2 levels due to mix of unequivocal (U), credible (C) and unsupported (US) findings: 21 U+4 C+2 US | Very low | Downgraded three levels due to dependability and credibility of primary studies |
| Resource generation | Qualitative | Moderate * | Downgraded 1 level due to mix of unequivocal (U) and credible (C): 9 U+2 C | Low | Downgraded two levels due to dependability and credibility of primary studies |
| Financing | Qualitative | Moderate * | Downgraded 1 level due to mix of unequivocal (U) and credible (C): 6 U+3 C | Low | Downgraded two levels due to dependability and credibility of primary studies |
| Stewardship | Qualitative | High * | Downgraded 1 level due to mix of unequivocal (U) and credible (C): 2 C+1U | Moderate | Downgraded one level due to credibility of primary studies |
*For synthesized finding 1, of the nine studies, three addressed four of the dependability questions, five addressed three, and one addressed two. So of the nine studies, six had moderate level and three had high level of dependability and the total level of dependability for synthesized finding 1 is moderate. For synthesized finding 2, of the three studies, one addressed four of the dependability questions, and two addressed three. Due to the equal number of high level and moderate level studies in this synthesized finding, we referred to the number of findings. Nine of the findings in synthesized finding 2 caught high level and two caught moderate level of dependability. For synthesized finding 3, the one study included have addressed three dependability questions. So the total level of dependability for synthesized finding 3 is moderate. For synthesized finding 4, the one study included have addressed four dependability questions. Therefore, the total level of dependability for synthesized finding 4 is high.
Search strategy
| Search name | Search query |
|---|---|
| #1 | (cancer[Title/Abstract]) OR cancers[Title/Abstract]) OR neoplasm[Title/Abstract]) OR neoplasms[Title/Abstract]) OR tumor[Title/Abstract]) OR tumors[Title/Abstract]) OR neoplasia[Title/Abstract]) OR neoplasias[Title/ Abstract]) OR malignancy[Title/Abstract]) OR malignancies[Title/Abstract] |
| #2 | (gastrointestinal[Title/Abstract]) OR digestive[Title/Abstract]) OR gastric[Title/Abstract]) OR stomach[Title/ Abstract]) OR stomachs[Title/Abstract]) OR esophagus[Title/Abstract]) OR esophageal[Title/ Abstract]) OR pancreas[Title/Abstract]) OR colon[Title/ Abstract]) OR colorectal[Title/Abstract]) OR liver[Title/ Abstract]) OR livers[Title/Abstract]) |
| #3 | (prevent*[Title/Abstract]) OR “secondary prevention”[Title/Abstract]) OR “secondary preventions”[Title/Abstract]) OR “early therapy”[Title/ Abstract]) OR “early therapies”[Title/Abstract]) OR “primordial prevention”[Title/Abstract]) OR “primordial preventions”[Title/Abstract]) OR “preventive therapy”[Title/Abstract]) OR “preventive therapies”[Title/ Abstract]) OR “preventive measures”[Title/Abstract]) OR “primary prevention”[Title/Abstract]) OR “primary preventions”[Title/Abstract]) OR screening[Title/ Abstract]) OR “early detection”[Title/Abstract]) OR “early diagnosis”[Title/Abstract]) |
| # 4 | (policy[Title/Abstract]) OR policies[Title/Abstract]) OR polic*[Title/Abstract]) OR plan[Title/Abstract]) OR program[Title/Abstract]) OR plans[Title/Abstract]) OR programs[Title/Abstract] |
| #5 | “1988/01/01”[PDAT] : “2018/06/31”[PDAT] |
| #6 | #1 AND #2 AND #3 AND #4 AND #5 |
|
| |
|
| |
|
| |
|
|
|
|
| |
| #1 | TI=(cancer OR cancers OR neoplasm OR neoplasms OR tumor OR tumors OR neoplasia OR neoplasias OR malignancy OR malignancies) |
| #2 | TI=(gastrointestinal OR digestive OR gastric OR stomach OR stomachs OR esophagus OR esophageal OR pancreas OR colon OR colorectal OR liver OR livers) |
| #3 | TI=(prevent* OR “secondary prevention” OR “secondary preventions” OR “early therapy” OR “early therapies” OR “primordial prevention” OR “primordial preventions” OR “preventive therapy” OR “preventive therapies” OR “preventive measures” OR “primary prevention” “early diagnosis” OR screening OR “early detection” OR “primary preventions”) |
| # 4 | TI=(policy OR policies OR polic* OR plan OR program OR plans OR programs) |
| #5 | </i>LANGUAGE: (English) |
| #6 | #1 AND #2 AND #3 AND #4 AND #5 |
|
| |
| SCOPUS, search date 2018/7/11 | |
|
| |
|
|
|
|
| |
| #1 | TITLE-ABS-KEY(cancer OR cancers OR neoplasm OR neoplasms OR tumor OR tumors OR neoplasia OR neoplasias OR malignancy OR malignancies) |
| #2 | TITLE-ABS-KEY(gastrointestinal OR digestive OR gastric OR stomach OR stomachs OR esophagus OR esophageal OR pancreas OR colon OR colorectal OR liver OR livers) |
| #3 | TITLE-ABS-KEY(prevent* OR “secondary prevention” OR “secondary preventions” OR “early therapy” OR “early therapies” OR “primordial prevention” OR “primordial preventions” OR “preventive therapy” OR “preventive therapies” OR “preventive measures” OR “primary prevention” “early diagnosis” OR screening OR “early detection” OR “primary preventions”) |
| # 4 | TITLE-ABS-KEY(policy OR policies OR polic* OR plan OR program OR plans OR programs) |
| #5 | PUBYEAR > 1988 |
| #6 | #1 AND #2 AND #3 AND #4 AND #5 |
|
| |
| ProQuest Dissertations and Thesis, search date 2018/7/15 | |
|
| |
|
|
|
|
| |
| #1 | (ti(cancer) OR ti(cancers) OR ti(neoplasm) OR ti(neoplasms) OR ti(tumor) OR ti(tumors) OR ti(neoplasia) OR ti(neoplasias) OR ti(malignancy) OR ti(malignancies)) AND (ti(gastrointestinal) OR ti(digestive) OR ti(gastric) OR ti(stomach) OR ti(liver) OR ti(esophagus) OR ti(esophageal) OR ti(pancreas) OR ti(colon) OR ti(colorectal)) |
| #2 | (ti(prevent*) OR ti(“secondary prevention”) OR ti(“early detection”) OR ti(“early therapy”) OR ti(screening) OR ti(“primordial prevention”) OR ti(“early diagnosis”) OR ti(“preventive therapy”) OR ti(“preventive therapies”) OR ti(“primary prevention”)) |
| #3 | (ti(policy) OR ti(policies) OR ti(polic*) OR ti(plan) OR ti(plans) OR ti(program) OR ti(programs)) |
| #6 | #1 AND #2 AND #3 |
Characteristics of included studies
| Study | Methodology | Phenomena of interest | Setting (geographically/clinically) | Participants | Data analysis | Data collection | Authors conclusion | Reviewer’s comment |
| Bridges, Gallego, Blauvelt (2011) | Qualitative methodology, not stated | Exploring clinicians’ perceptions of current public policy needs for controlling liver cancer internationally | Geographically: Asia, Europe, and North America (11 countries) | Liver cancer clinicians being involved in policy and related disease prevention, detection, and management. ( | Constant comparative method | In-depth semi structured interviews | There were identified different needs including improving prevention, awareness and financial support for liver cancer control. These needs were similar in studied countries, although health policy in all countries differs from each other. | Conclusions drawn from the results relate to the aims of the study. |
| Jilcott Pitts, Lea, May, Stowe, Hamill, Walker, Fitzgerald (2013) | Qualitative methodology, not stated | Examination of barriers and facilitators to colorectal cancer screening | Geographically: Eastern North Carolina, Bertie County. Economically: The percentage of persons living below the poverty level was 24%. Clinically: Bertie County carries a heavy burden of colorectal cancer mortality and incidence. Socially: Educational attainment levels are lower in Bertie County with 9.6% of Bertie County residents over the age of 25 having a bachelor’s degree or higher. | Bertie County residents ( | Framework analysis | Focus group discussions ( | The identified barriers and facilitators help policy makers to design new strategies for colorectal cancer screening to reduce disparities. | Conclusions drawn from the results relate to the aims of the study. |
| Buchman, Rozmovits, Glazier (2016) | Mixed method study, Qualitative descriptive study | Assessing equity and practice issues in colorectal cancer screening | Geographically: Toronto Clinically: A setting with large disparities in other forms of cancer screening and relatively good access to colonoscopy through hospital based services and private endoscopy clinics. | Physicians from 12 family health teams ( | Thematic analysis using constant comparative method | Semi structured telephone interviews | Providing an informed choice of screening method to patients might result in higher screening rates and fewer disparities. | Clear outline both the methods and methodology. |
| Clavarino, Janda, Hughes, Mar, Tong, Stanton, Aitken, Leggett, Newman (2004) | Qualitative methodology, not stated | Exploring community and medical perspectives on screening for colorectal cancer using FOBT | Geographically: a rural Queensland community with a population of approximately 4200 residents aged 50 years or older. Clinically: The area is situated approximately 100 km from a large regional centre with the necessary facilities to provide colonoscopy followup | People known to have completed an FOBT. ( | Iterative inductive analysis | Focus group discussion, Semi structured interview (telephone interview) | Information about the objectives of screening programs, in general, and the efficacy of FOBT screening in particular, needs to be provided to the community to ensure informed individual choice. | Conclusions drawn from theresults relate tothe aims of the study. |
| Dowson, Crane, Lyons, Burnham, Bowman, Perez, Travaglia (2017) | Qualitative methodology, pragmatic | General practitioners’ perceptions of population based bowel screening and their influence on practice | Geographically: metropolitan and regional New South Wales (NSW), Australia | General Physicians ( | Thematic analysis | Semistructured interviews | The findings suggest a greater emphasis on the preventative opportunity of FOBT screening would be beneficial, as would formally engaging GPs in the promotion of bowel screening. | There was congruity between methods and the research question. |
| Dowswell, Ryan, Taylor, Daley, Freemantle, Brookes, Jones, Haslop, Grimmett, Cheng, Sue (2012) | Qualitative methodology, not stated | Assessing patients’ preferences for appropriate and acceptable dietary and physical activity interventions. | Geographically: England Clinically: patients were selected from the Royal Wolverhampton Hospitals NHS Trust patient tracking database and had been diagnosed with a I/HRA at colonoscopy after a positive faecal occult blood test (FOBt). | Patients ( | Thematic analysis | Focus groups ( | Without a full understanding of the role of high risk polyps in the etiology of colorectal cancer, the motivation to change entrenched behaviors (such as inadequate physical activity and a diet that includes high levels of red and processed meats) may be lacking. | There was congruity between methods and the research question. |
| Goel, Gray, Chart, Fitch, Saibil, Zdanowicz (2004) | Qualitative methodology, not stated | Assessing attitudes and acceptability of consumers and doctors towards colorectal screening with faecal occult blood testing (FOBT) and colonoscopy. | Geographically: Toronto and Kitchener | Patients ( | Thematic analysis | Focus groups ( | Implementation of colorectal screening programs requires substantial educational efforts for both consumers and doctors. | Conclusions drawn from theresults relate tothe aims of the study. |
| Liles, Schneider, Feldstein, Mosen, Perrin, Rosales, Smith (2015) | Qualitative methodology, not stated | Exploring implementation challenges and successes of a populationbased colorectal cancer screening program | Geographically: Washington and the Portland, Oregon Clinically: a not for profit group model health maintenance organization (HMO) with about 485,000 members in Southern Washington and the Portland, Oregon, metro area | Health plan leaders ( | Content analysis | Interview, focus group | The majority of stakeholders at various levels consistently reported that an automated telephonereminder system to contact patients and coordinate mailing fecal tests alleviated organizational constraints on staff’s time and resources. | There was congruity between methods and the research question. |
| Sarfaty, Stello, Johnson, Sifri, Borsky, Myers (2013) | Qualitative methodology, not stated | Colorectal Cancer screening in the Framework of the medical home Model | Geographically: unclear Clinically: Primary care practices | Office managers, clinicians, clinical team members, and office staff | Thematic analysis | Interview, focus group | Many practices lacked a systematic way to identify patients who were not up to date on screening while they were visiting the practice, thereby passing up the best opportunity to reach them. | Results reported in this study summarized survey findingsof an earlier publication. |
Study findings and illustrations
| Bridges JF, Gallego G, Blauvelt BM. Controlling liver cancer internationally: A qualitative study of clinicians’ perceptions of current public policy needs. Health research policy and systems. 2011;28;9(32):1-8. | ||
|
| ||
|
|
|
|
|
| ||
| Prevention of viral hepatitis (B and C) mostly through vaccination |
| Unequivocal |
| Early risk assessment for Hepatocellular Carcinoma (HCC) |
| Unequivocal |
| Modification of risk factors such as alcohol use, obesity and diabetes for HCC |
| Unequivocal |
| Improving awareness among policy makers about importance of HCC |
| Credible |
| Increasing public awareness about importance of HCC through education by health campaigns and media exposure | Unequivocal | |
| Educating primary care physicians about importance of liver disease and related risk factors |
| Unequivocal |
| Increasing political (government) awareness |
| Credible |
| Developing mandatory screening guidelines and systems for HCC |
| Credible |
| Better allocation of funds for screening programs |
| Unequivocal |
| Improving surveillance of incidence, prevalence and burden of liver cancer through financial support |
| Unequivocal |
|
| ||
| Jilcott Pitts SB, Lea CS, May CL, Stowe C, Hamill DJ, Walker KT, | ||
|
| ||
|
|
|
|
|
| ||
| Free colorectal cancer screening tests |
| Unequivocal |
| Building walkin clinics |
| Unequivocal |
| Providing followup information for screening results as needed |
| Unequivocal |
| Public education about screening |
| Unequivocal |
|
| ||
| Buchman S, Rozmovits L, Glazier RH. Equity and practice issues in colorectal cancer screening: Mixed-.methods study. Canadian family physician. 2016;62(4):186-.93. | ||
|
| ||
|
|
|
|
|
| ||
| Fecal occult blood testing (FOBT) |
| Unequivocal |
| Colonoscopy |
| Credible |
| Socioeconomic differences among patients |
| Unequivocal |
|
| ||
| Clavarino AM, Janda M, Hughes KL, Del Mar C, Tong S, Stanton WR, | ||
|
| ||
|
|
|
|
|
| ||
| Distribution of the FOBT kit by mail for colorectal screening |
| Unequivocal |
| Dawson G, Crane M, Lyons C, Burnham A, Bowman T, Perez D, | ||
|
| ||
|
|
|
|
|
| ||
| Screening of population at certain age | “I think the studies so far have shown that if we do screen the population at certain ages, that it does seem to pick up some of the bowel cancers earlier and therefore it’s a good thing to do.” (p4) | Unequivocal |
| Importance of targeting the asymptomatic population | “What I see is to pick up cancer in the asymptomatic population, and the higher the pickup rate, the better the outcome because it’s fixable in the early stages, it’s treatable. So my role is to pick up [cancer] early, as soon as possible.” (p4) | Unequivocal |
| Flexible sigmoidoscopy | - | Unsupported |
|
| ||
| Dowswell G, Ryan A, Taylor A, Daley A, Freemantle N, Brookes M, | ||
|
| ||
|
|
|
|
|
| ||
| Physical activity for intermediate or high risk colorectal adenoma | “But my problem is I can walk now because I’ve just retired but for the last ten years I’ve been working nights. So when I’m awake my wife’s asleep and the other way round, we only ever used to meet at weekends. So we’d perhaps slot one walk in but for ten years we hardly did anything at all. And I put on weight and ate some horrible food and now my life is changing so we’re back to walking again now.”(p6) | Credible |
| Consumption of red meat for intermediate or high risk colorectal adenoma | “Oh yeah, I’ve cut it tremendously down, even in the week. The only time we really eat red meat is if we have a Sunday lunch”(p6) | Credible |
|
| ||
| Goel V, Gray R, Chart P, Fitch M, Saibil F, Zdanowicz Y. Perspectives on colorectal cancer screening: A focus group study. Health Expectations. 2004;7(1):51-.60. | ||
|
| ||
|
|
|
|
|
| ||
| FOBT for colon cancer screening | “At least [its] not painful…it’s in privacy of your own home”(p56) | Unequivocal |
| Sigmoidoscopy | Unsupported | |
|
| ||
| Liles EG, Schneider JL, Feldstein AC, Mosen DM, Perrin N, Rosales AG, | ||
|
| ||
|
|
|
|
|
| ||
| Too many options in the system for screening and no clear guidelines for providers or patients | “It’s amazing the paucity of evidence around what’s really the best test. The stool cards have been tested more rigorously than other interventions, so we know more about that. But that doesn’t necessarily mean we know that colonoscopy is not as good.”(p6) | Unequivocal |
| Referral process for a screening colonoscopy involves multiple steps and departments, which sometimes creates miscommunication and lack of followup | “The referral is more challenging than for something like a Pap, which I can do it when they come in. I have more control over that. As opposed to CRC screening [colonoscopy] and having to send in a referral, having the patient be called back or a letter sent. It’s just more steps to get in.” (p6) | Unequivocal |
| Overall focus on quality and prevention as a primary part of organization’s mission and values | “The one thing we don’t argue is that we need screening of some type for colon cancer. Everyone knows the old adage is that any screen is better than no screening. So we all agree that we need to get there to screen the population. And we’ve got to decide what’s the best way to do it for our population.” (p7) | Credible |
| Trust in the structure of the integrated health system to enable alignment of evidencebased CRC screening approaches with available resources and department roles | “And I know that, you know, we had a very strong analyst. We had a very strong negotiator. We had a strong physician lead who was very interested and extremely engaged. And then we had a project manager, I mean, that could just kind of manage all the pieces and make sure that everybody shows up and things are done in a timeline.” (p7) | Credible |
| Use of support staff (medical assistants) trained in educating and motivating patients on screening and followup | “We have our own MAs and own staff and we can say, okay, when a patient checks in and they’re due for one of these, you hand them this. If there’s no need, not involving the physician just speeds up things. If you have a nice handout and your staff is knowledgeable about the task and can explain it to somebody, like an MA, there’s no reason for taking time out of an appointment for the physician to go over the test, when the patient is there for something else. So finding the earliest person who is able to deliver the message early on is better.” (p7) | Unequivocal |
| Presence of PCP champions to assist other providers in navigating and integrating latest research with organizational goals and patient demand | “Presentations and talks [with clinician champion] have really been helpful. They have helped me kind of frame my conversations about everything… having a clinician who has looked at the research is really powerful.” (p7) | Unequivocal |
| Access and utilization to EMR tools that help identify screening gap or indicate prior completed screening. Recent emphasis on increasing access to colonoscopy | “Systematically we are pretty good at reaching out to people and [we] have pretty good tools to identify them. We know who they are. We know what they need. And, we have a pretty good process to tell them what they need and to try to connect the dots for them.” (p7) | Unequivocal |
| Use of automated telephone outreach for CRC screening | “For colon cancer screening, what we pretty much have always done is inreach during a visit… having an automated program makes it easier for us—especially for reaching those people whom we never see [in a visit] and tend to miss.”(p9) | Unequivocal |
| Education and communication about resource stewardship and evidence based outcomes as it pertains to CRC screening seen as helpful | “Just recently, we’ve actually fed back to physicians, what their colonoscopy rate was versus their colleague who has the same risk adjusted population. And, some doctors were just mortified that they were sending out twenty times more than the doctor down the hall who had patients that weren’t that different… so as an organization, we owe all of our patients a research stewardship perspective.” (p10) | Unequivocal |
| Need to make CRC screening a selfreferral program, similar to other screening programs (e.g., breast cancer screening) | “Make it selfreferral”. (p13) | Unequivocal |
|
| ||
| Sarfaty M, Stello B, Johnson M, Sifri R, Borsky A, Myers RM. Colorectal cancer screening in the framework of the medical home model: findings from focus groups and interviews. American journal of medical quality: the official journal of the American College of Medical Quality. 2013;28(5):422-.8. | ||
|
| ||
|
|
|
|
|
| ||
| Enhance access and communication between team | “Yes, [we have a policy for] anyone over 50. The process is, if we are seeing a patient, the chart is pulled and prepared the day before. We look and see what the patient needs and put on a sticky note. The provider addresses the issue and makes a referral to a surgeon. Then the front office sets up the appointment with the surgeon. The provider reminds patients to be screened. Charts are audited all the time by clinical staff. The office manager/ practitioner reviews test results when they are returned and schedules appropriate followup.” (p424) | Unequivocal |
| Identify and manage populations for CRC | “I think it would be nice if we did have a systematic way to identify those that are not getting them and should be getting them. That being said, it almost always requires a discussion with a patient’s primary care physician about what this is. So I think it would be nice to track the data, send a letter out saying to go for your colorectal cancer screening. Talk to your doctor next time …even if they get that letter and the doctor doesn’t mention it.”(p425) | Unequivocal |
| Plan and manage care for CRC | “Yes, it goes in their medical record in the EMR when they get the screening done. So we review it at each appointment. At each checkup appointment, we review the health maintenance screen, and it will have on it whether or not they are up to date with their colorectal screen.”(p425) | Credible |
| Selfcare and community resources for CRC | “We all participate in patient education. Most of it is done by providers and clinical staff. We do have a rack of brochures on patient education and use printouts of educational materials approved by the hospital.”(p426) | Unequivocal |
| Track and coordinate care: referral tracking for CRC | “We do know about our referrals, like colonoscopies, which is (the type of test we usually use)—Dr (name) and I would refer them, then our staff will make sure that the referral carries through. But are we closing that hole whether it was done or not? Are we following up on that? We are not there yet.”(p427) | Unequivocal |
| Measure and improve performance: implement continuous quality improvement for CRC | “I think, moving forward, this is one thing we’ve discussed doing in regards to a quality improvement initiative is preventive maintenance tracking, including colorectal cancer screening and mammographies and the rest of that stuff…. We just haven’t gotten to that point yet.”(p428) | Unequivocal |
Results of meta-synthesis
| Meta synthesis 1 | ||
| Findings | Categories | Synthesized finding |
| Prevention of viral hepatitis (B and C) mostly through vaccination | Managing risk factors of the population | |
| Early risk assessment for Hepatocellular Carcinoma (HCC) | ||
| Modification of risk factors such as alcohol use, obesity and diabetes for HCC | ||
| Physical activity for intermediate or high risk colorectal adenoma | ||
| Consumption of red meat for intermediate or high risk colorectal adenoma | ||
| Fecal occult blood testing (FOBT) | Clinical methods of population screening | |
| Colonoscopy | ||
| Sigmoidoscopy | ||
| Increasing public awareness about importance of HCC through education by health | Enhancing knowledge of population | |
| campaigns and media exposure | ||
| Public education about screening | ||
| Use of support staff (medical assistants) trained in educating and motivating patients on screening and follow-up | ||
| Self-care and community resources for colorectal cancer (CRC) | ||
| Providing follow-up information for screening results as needed | Service provision | |
| Identify and manage populations for CRC | Population management | |
| Screening of population at certain age | ||
| Importance of targeting the asymptomatic population | ||
| Plan and manage care for CRC | Care management | |
| Track and coordinate care: referral tracking for CRC | ||
| Measure and improve performance: implement continuous quality improvement for CRC | ||
| Free colorectal cancer screening tests | Increasing access to care | |
| Building walk-in clinics | ||
| Distribution of the FOBT kit by mail for colorectal screening | ||
| Socioeconomic differences among patients | ||
| Need to make CRC screening a self-referral program, similar to other screening | ||
| programs (e.g., breast cancer screening) | ||
| Referral process for a screening colonoscopy involves multiple steps and departments, which sometimes creates miscommunication and lack of follow-up | ||
|
| ||
|
| ||
|
| ||
|
|
|
|
|
| ||
| Developing mandatory screening guidelines and systems for HCC | Guideline development | |
| Too many options in the system for screening and no clear guidelines for providers or patients | ||
| Education and communication about resource stewardship and evidence based outcomes as it pertains to CRC screening seen as helpful | Enhancing provider ability | |
| Enhance access and communication between team | ||
| Educating primary care physicians about importance of liver disease and related risk factors | Enhancing knowledge among providers | Resource generation |
| Increasing political (government) awareness | ||
| Improving awareness among policy makers about importance of HCC | ||
| Access and utilization to EMR tools that help identify screening gap or indicate prior completed screening | Use of technology | |
| Use of automated telephone outreach for CRC screening | ||
|
| ||
|
| ||
|
| ||
|
|
|
|
|
| ||
| Improving surveillance of incidence, prevalence and burden of liver cancer through financial support Better allocation of funds for screening programs | Financial support | Financing |
|
| ||
|
| ||
|
| ||
|
|
|
|
|
| ||
| Overall focus on quality and prevention as a primary part of organization’s mission and values Trust in the structure of the integrated health system to enable alignment of evidence-based CRC screening approaches with available resources and department roles Presence of primary care champions to assist other providers in navigating and integrating latest research with organizational goals and patient demand | Organizational factors | Stewardship |